Gene Symbol | Gene ID | Gene Info |
---|---|---|
NKX2-2
|
ENSG00000125820.5 | NK2 homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr20_21501454_21501605 | NKX2-2 | 6865 | 0.225083 | 0.67 | 4.7e-02 | Click! |
chr20_21528926_21529077 | NKX2-2 | 34337 | 0.176605 | -0.55 | 1.3e-01 | Click! |
chr20_21538382_21538533 | NKX2-2 | 43793 | 0.157380 | -0.51 | 1.6e-01 | Click! |
chr20_21538130_21538281 | NKX2-2 | 43541 | 0.157894 | -0.45 | 2.3e-01 | Click! |
chr20_21495239_21495416 | NKX2-2 | 663 | 0.719751 | -0.24 | 5.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_118745072_118745584 | 0.67 |
TAOK3 |
TAO kinase 3 |
51464 |
0.15 |
chr5_39423780_39424080 | 0.66 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
1040 |
0.66 |
chr1_224805949_224806359 | 0.48 |
CNIH3 |
cornichon family AMPA receptor auxiliary protein 3 |
2159 |
0.29 |
chr7_77930640_77930829 | 0.47 |
RP5-1185I7.1 |
|
310997 |
0.01 |
chr1_158969828_158970040 | 0.45 |
IFI16 |
interferon, gamma-inducible protein 16 |
176 |
0.96 |
chr1_218672576_218672996 | 0.44 |
C1orf143 |
chromosome 1 open reading frame 143 |
10652 |
0.26 |
chr6_56707059_56707245 | 0.43 |
DST |
dystonin |
791 |
0.6 |
chr14_33045621_33045875 | 0.42 |
AKAP6 |
A kinase (PRKA) anchor protein 6 |
81470 |
0.11 |
chr3_8809480_8810320 | 0.42 |
OXTR |
oxytocin receptor |
463 |
0.76 |
chr1_156091066_156091427 | 0.40 |
LMNA |
lamin A/C |
4705 |
0.12 |
chr7_94027358_94027511 | 0.39 |
COL1A2 |
collagen, type I, alpha 2 |
3561 |
0.34 |
chr4_4494063_4494282 | 0.39 |
STX18-IT1 |
STX18 intronic transcript 1 (non-protein coding) |
10745 |
0.21 |
chr12_91573704_91574005 | 0.38 |
DCN |
decorin |
288 |
0.94 |
chr1_164532131_164532342 | 0.38 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
194 |
0.97 |
chr13_77457508_77457742 | 0.37 |
KCTD12 |
potassium channel tetramerization domain containing 12 |
2900 |
0.26 |
chr3_132316198_132316509 | 0.37 |
ACKR4 |
atypical chemokine receptor 4 |
272 |
0.93 |
chr7_17030060_17030455 | 0.37 |
AGR3 |
anterior gradient 3 |
108646 |
0.07 |
chr3_132315920_132316071 | 0.37 |
ACKR4 |
atypical chemokine receptor 4 |
86 |
0.98 |
chr2_188312053_188312458 | 0.36 |
CALCRL |
calcitonin receptor-like |
724 |
0.77 |
chr19_16403865_16404198 | 0.36 |
CTD-2562J15.6 |
|
355 |
0.85 |
chr14_81866312_81866672 | 0.36 |
STON2 |
stonin 2 |
1565 |
0.55 |
chr11_121968562_121968780 | 0.35 |
ENSG00000207971 |
. |
1881 |
0.27 |
chr5_72147028_72147179 | 0.35 |
TNPO1 |
transportin 1 |
3092 |
0.26 |
chr5_98118231_98118548 | 0.35 |
RGMB |
repulsive guidance molecule family member b |
9050 |
0.23 |
chr9_2838300_2838770 | 0.35 |
KIAA0020 |
KIAA0020 |
5706 |
0.3 |
chr13_76020093_76020271 | 0.35 |
TBC1D4 |
TBC1 domain family, member 4 |
36068 |
0.18 |
chr1_101359369_101359680 | 0.35 |
EXTL2 |
exostosin-like glycosyltransferase 2 |
696 |
0.48 |
chr2_66664825_66665240 | 0.35 |
MEIS1 |
Meis homeobox 1 |
93 |
0.96 |
chr13_95255061_95255225 | 0.34 |
GPR180 |
G protein-coupled receptor 180 |
986 |
0.56 |
chr4_81191707_81191903 | 0.34 |
FGF5 |
fibroblast growth factor 5 |
4012 |
0.29 |
chr4_119948824_119949052 | 0.34 |
SYNPO2 |
synaptopodin 2 |
4312 |
0.32 |
chr11_101983358_101983513 | 0.34 |
YAP1 |
Yes-associated protein 1 |
190 |
0.94 |
chr11_121969171_121969347 | 0.34 |
ENSG00000207971 |
. |
1293 |
0.36 |
chr4_151062450_151062706 | 0.33 |
DCLK2 |
doublecortin-like kinase 2 |
62398 |
0.13 |
chr12_94761705_94761856 | 0.33 |
ENSG00000244391 |
. |
6784 |
0.22 |
chr20_17538596_17539086 | 0.33 |
BFSP1 |
beaded filament structural protein 1, filensin |
642 |
0.72 |
chr5_52136022_52136457 | 0.33 |
CTD-2288O8.1 |
|
52379 |
0.13 |
chr2_175203994_175204145 | 0.33 |
AC018470.1 |
Uncharacterized protein FLJ46347 |
1918 |
0.29 |
chr11_120195755_120196855 | 0.33 |
TMEM136 |
transmembrane protein 136 |
289 |
0.9 |
chr11_74494468_74494674 | 0.32 |
ENSG00000264095 |
. |
29942 |
0.12 |
chr20_46121886_46122388 | 0.32 |
ENSG00000201742 |
. |
308 |
0.88 |
chr12_56916774_56917003 | 0.32 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
1105 |
0.41 |
chr1_178269315_178269642 | 0.32 |
RASAL2 |
RAS protein activator like 2 |
41128 |
0.2 |
chr1_119524620_119524878 | 0.32 |
TBX15 |
T-box 15 |
5679 |
0.29 |
chr2_53803027_53803274 | 0.32 |
ENSG00000207456 |
. |
5533 |
0.28 |
chr1_89197420_89197765 | 0.31 |
PKN2 |
protein kinase N2 |
39546 |
0.16 |
chr1_179111271_179111703 | 0.31 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
692 |
0.72 |
chr7_91923432_91923918 | 0.31 |
ANKIB1 |
ankyrin repeat and IBR domain containing 1 |
101 |
0.97 |
chr9_110248378_110248529 | 0.31 |
KLF4 |
Kruppel-like factor 4 (gut) |
2958 |
0.29 |
chr3_185741982_185742377 | 0.31 |
ENSG00000266670 |
. |
42096 |
0.14 |
chr9_73539563_73539988 | 0.31 |
TRPM3 |
transient receptor potential cation channel, subfamily M, member 3 |
55801 |
0.16 |
chr14_59949074_59949274 | 0.31 |
L3HYPDH |
L-3-hydroxyproline dehydratase (trans-) |
1229 |
0.4 |
chr18_52919735_52919886 | 0.31 |
TCF4 |
transcription factor 4 |
23092 |
0.25 |
chr18_34252707_34252889 | 0.31 |
ENSG00000252078 |
. |
30151 |
0.2 |
chr10_15546629_15546846 | 0.31 |
FAM171A1 |
family with sequence similarity 171, member A1 |
133676 |
0.05 |
chr6_116833589_116833880 | 0.30 |
TRAPPC3L |
trafficking protein particle complex 3-like |
228 |
0.83 |
chr8_105236286_105236489 | 0.30 |
RIMS2 |
regulating synaptic membrane exocytosis 2 |
507 |
0.87 |
chr8_49447973_49448420 | 0.30 |
RP11-770E5.1 |
|
15931 |
0.3 |
chr3_145968034_145968185 | 0.30 |
PLSCR4 |
phospholipid scramblase 4 |
545 |
0.85 |
chr1_96354702_96354941 | 0.30 |
ENSG00000221798 |
. |
2725 |
0.41 |
chr13_80824494_80824698 | 0.29 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
89198 |
0.1 |
chr6_132452290_132452699 | 0.29 |
ENSG00000265669 |
. |
16091 |
0.27 |
chr14_52821800_52821992 | 0.29 |
PTGER2 |
prostaglandin E receptor 2 (subtype EP2), 53kDa |
40783 |
0.18 |
chr3_114369992_114370143 | 0.29 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
26275 |
0.25 |
chr6_161649839_161650239 | 0.29 |
AGPAT4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
45012 |
0.2 |
chr21_47404119_47404503 | 0.29 |
COL6A1 |
collagen, type VI, alpha 1 |
2660 |
0.29 |
chr5_54456456_54456818 | 0.29 |
GPX8 |
glutathione peroxidase 8 (putative) |
639 |
0.58 |
chr12_88810686_88810837 | 0.28 |
ENSG00000199245 |
. |
13458 |
0.29 |
chr8_117466815_117467042 | 0.28 |
ENSG00000264815 |
. |
167340 |
0.04 |
chr1_200710499_200710966 | 0.28 |
CAMSAP2 |
calmodulin regulated spectrin-associated protein family, member 2 |
1825 |
0.44 |
chr5_44389781_44390058 | 0.28 |
FGF10 |
fibroblast growth factor 10 |
111 |
0.95 |
chr12_19284782_19284948 | 0.28 |
PLEKHA5 |
pleckstrin homology domain containing, family A member 5 |
2135 |
0.35 |
chr11_46300696_46300847 | 0.28 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
1543 |
0.37 |
chr17_21163251_21163402 | 0.28 |
C17orf103 |
chromosome 17 open reading frame 103 |
6604 |
0.17 |
chrX_114849372_114849580 | 0.28 |
PLS3 |
plastin 3 |
4921 |
0.25 |
chr2_198539715_198539970 | 0.28 |
RFTN2 |
raftlin family member 2 |
877 |
0.6 |
chr10_76050173_76050375 | 0.28 |
ADK |
adenosine kinase |
113753 |
0.06 |
chr8_38857241_38857490 | 0.28 |
ADAM9 |
ADAM metallopeptidase domain 9 |
2860 |
0.19 |
chr8_116264905_116265143 | 0.27 |
TRPS1 |
trichorhinophalangeal syndrome I |
239424 |
0.02 |
chr2_153348906_153349057 | 0.27 |
FMNL2 |
formin-like 2 |
127111 |
0.06 |
chr13_101202740_101202924 | 0.27 |
RP11-151A6.4 |
|
10772 |
0.19 |
chr6_139692941_139693119 | 0.27 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
2320 |
0.4 |
chr6_152701268_152701555 | 0.27 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
270 |
0.91 |
chr7_56160445_56160611 | 0.27 |
PHKG1 |
phosphorylase kinase, gamma 1 (muscle) |
97 |
0.94 |
chr3_146755933_146756085 | 0.27 |
ENSG00000207156 |
. |
41509 |
0.2 |
chr2_163099691_163099877 | 0.27 |
FAP |
fibroblast activation protein, alpha |
182 |
0.96 |
chr3_159483781_159484285 | 0.27 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
1141 |
0.44 |
chr5_55420029_55420180 | 0.27 |
ENSG00000253032 |
. |
1394 |
0.4 |
chr1_198057970_198058261 | 0.27 |
NEK7 |
NIMA-related kinase 7 |
67978 |
0.13 |
chr2_159610172_159610621 | 0.27 |
AC005042.4 |
|
18882 |
0.21 |
chr4_170188672_170188986 | 0.26 |
SH3RF1 |
SH3 domain containing ring finger 1 |
2279 |
0.41 |
chr4_87052385_87052536 | 0.26 |
RP11-778J15.1 |
|
11593 |
0.23 |
chr3_145877576_145877727 | 0.26 |
PLOD2 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
1128 |
0.57 |
chr5_141920833_141921059 | 0.26 |
ENSG00000252831 |
. |
7036 |
0.25 |
chr4_114899439_114899761 | 0.26 |
ARSJ |
arylsulfatase family, member J |
552 |
0.84 |
chr15_49758482_49758645 | 0.26 |
FGF7 |
fibroblast growth factor 7 |
43106 |
0.17 |
chr2_220942198_220942388 | 0.26 |
ENSG00000221199 |
. |
114306 |
0.06 |
chr3_73159675_73159826 | 0.26 |
ENSG00000223247 |
. |
393 |
0.83 |
chr18_6030976_6031127 | 0.26 |
RP11-793A3.2 |
|
5961 |
0.23 |
chr9_91929257_91929464 | 0.26 |
ENSG00000265112 |
. |
2220 |
0.26 |
chr18_7579845_7579996 | 0.26 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
12103 |
0.29 |
chr2_171700467_171700658 | 0.26 |
GAD1 |
glutamate decarboxylase 1 (brain, 67kDa) |
21965 |
0.15 |
chr10_96163775_96164021 | 0.26 |
TBC1D12 |
TBC1 domain family, member 12 |
1637 |
0.43 |
chr13_32786329_32786590 | 0.26 |
FRY |
furry homolog (Drosophila) |
52346 |
0.14 |
chr14_90126270_90126545 | 0.26 |
ENSG00000252655 |
. |
9160 |
0.16 |
chr1_51438505_51438667 | 0.25 |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
2970 |
0.28 |
chr2_169374767_169374972 | 0.25 |
CERS6 |
ceramide synthase 6 |
62110 |
0.1 |
chr8_99740073_99740224 | 0.25 |
STK3 |
serine/threonine kinase 3 |
97751 |
0.08 |
chr7_27236053_27236457 | 0.25 |
HOTTIP |
HOXA distal transcript antisense RNA |
1939 |
0.13 |
chr9_21591325_21591685 | 0.25 |
MIR31HG |
MIR31 host gene (non-protein coding) |
31837 |
0.16 |
chr1_214618329_214618746 | 0.25 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
19609 |
0.26 |
chr15_36623332_36623712 | 0.25 |
C15orf41 |
chromosome 15 open reading frame 41 |
248290 |
0.02 |
chr5_43308499_43308850 | 0.25 |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
4652 |
0.23 |
chr12_116037117_116037430 | 0.25 |
ENSG00000240205 |
. |
118257 |
0.07 |
chr18_46020104_46020474 | 0.25 |
ENSG00000200872 |
. |
18318 |
0.21 |
chr7_18549761_18549974 | 0.25 |
HDAC9 |
histone deacetylase 9 |
931 |
0.71 |
chr6_40687581_40687836 | 0.25 |
LRFN2 |
leucine rich repeat and fibronectin type III domain containing 2 |
132504 |
0.05 |
chr11_48039463_48039614 | 0.25 |
AC103828.1 |
|
2131 |
0.35 |
chr2_8143991_8144314 | 0.24 |
ENSG00000221255 |
. |
427180 |
0.01 |
chr17_31239173_31239327 | 0.24 |
TMEM98 |
transmembrane protein 98 |
15678 |
0.17 |
chr10_95196659_95197038 | 0.24 |
MYOF |
myoferlin |
45103 |
0.14 |
chr1_13910795_13911459 | 0.24 |
PDPN |
podoplanin |
362 |
0.87 |
chr2_38373660_38374056 | 0.24 |
ENSG00000199603 |
. |
699 |
0.72 |
chr13_35963746_35963897 | 0.24 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
87011 |
0.09 |
chr4_116464375_116464526 | 0.24 |
NDST4 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 |
429418 |
0.01 |
chr3_157154723_157155399 | 0.24 |
PTX3 |
pentraxin 3, long |
483 |
0.86 |
chr1_167693043_167693194 | 0.24 |
MPZL1 |
myelin protein zero-like 1 |
1729 |
0.44 |
chr7_129850493_129850759 | 0.24 |
SSMEM1 |
serine-rich single-pass membrane protein 1 |
2926 |
0.19 |
chr13_80066771_80066922 | 0.24 |
NDFIP2 |
Nedd4 family interacting protein 2 |
11258 |
0.21 |
chr2_18595221_18595519 | 0.24 |
RDH14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
146576 |
0.04 |
chr15_71504267_71504460 | 0.24 |
RP11-673C5.2 |
|
22982 |
0.23 |
chr4_175055764_175055915 | 0.24 |
FBXO8 |
F-box protein 8 |
148975 |
0.04 |
chr3_25193430_25193657 | 0.24 |
RARB |
retinoic acid receptor, beta |
22280 |
0.26 |
chr11_10229350_10229501 | 0.23 |
RP11-748C4.1 |
|
58686 |
0.12 |
chr7_77388461_77388692 | 0.23 |
RSBN1L |
round spermatid basic protein 1-like |
336 |
0.9 |
chr14_69709628_69709779 | 0.23 |
GALNT16 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
16978 |
0.2 |
chr1_101334241_101334590 | 0.23 |
EXTL2 |
exostosin-like glycosyltransferase 2 |
25805 |
0.15 |
chr1_55701423_55701577 | 0.23 |
ENSG00000265822 |
. |
10186 |
0.23 |
chr18_12306690_12306841 | 0.23 |
TUBB6 |
tubulin, beta 6 class V |
903 |
0.54 |
chr5_95403437_95403808 | 0.23 |
ENSG00000207578 |
. |
11220 |
0.25 |
chr12_91092431_91092582 | 0.23 |
CCER1 |
coiled-coil glutamate-rich protein 1 |
256447 |
0.02 |
chr5_39421239_39421390 | 0.23 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
3656 |
0.34 |
chr7_120632569_120632731 | 0.23 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
2974 |
0.27 |
chr2_161274557_161274766 | 0.23 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
1972 |
0.35 |
chr3_127633934_127634403 | 0.23 |
KBTBD12 |
kelch repeat and BTB (POZ) domain containing 12 |
93 |
0.98 |
chrX_105951632_105951877 | 0.23 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
14686 |
0.24 |
chr5_142880921_142881072 | 0.23 |
ENSG00000253023 |
. |
41156 |
0.18 |
chr4_83996791_83996942 | 0.23 |
PLAC8 |
placenta-specific 8 |
34130 |
0.14 |
chr16_27256849_27257000 | 0.23 |
NSMCE1 |
non-SMC element 1 homolog (S. cerevisiae) |
12525 |
0.16 |
chr4_99544258_99544409 | 0.23 |
TSPAN5 |
tetraspanin 5 |
34453 |
0.18 |
chr10_13754786_13755077 | 0.23 |
RP11-295P9.6 |
|
2516 |
0.19 |
chr5_95068939_95069254 | 0.23 |
CTD-2154I11.2 |
|
1097 |
0.44 |
chr11_14375529_14375805 | 0.23 |
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
379 |
0.91 |
chr1_178064247_178064419 | 0.23 |
RASAL2 |
RAS protein activator like 2 |
1057 |
0.69 |
chrX_102940107_102940387 | 0.23 |
MORF4L2 |
mortality factor 4 like 2 |
902 |
0.43 |
chr15_96878465_96878729 | 0.22 |
ENSG00000222651 |
. |
2107 |
0.24 |
chr8_19148668_19149118 | 0.22 |
SH2D4A |
SH2 domain containing 4A |
22235 |
0.28 |
chr1_218550498_218550696 | 0.22 |
TGFB2 |
transforming growth factor, beta 2 |
31020 |
0.18 |
chr1_203631994_203632193 | 0.22 |
ATP2B4 |
ATPase, Ca++ transporting, plasma membrane 4 |
19844 |
0.21 |
chr5_171269419_171269604 | 0.22 |
SMIM23 |
small integral membrane protein 23 |
56621 |
0.13 |
chr6_136809157_136809308 | 0.22 |
MAP7 |
microtubule-associated protein 7 |
21219 |
0.2 |
chr2_225276641_225276966 | 0.22 |
FAM124B |
family with sequence similarity 124B |
10001 |
0.29 |
chr4_81177063_81177214 | 0.22 |
FGF5 |
fibroblast growth factor 5 |
10615 |
0.24 |
chr3_130648403_130648554 | 0.22 |
RP11-39E3.3 |
|
342 |
0.49 |
chr13_50650646_50650797 | 0.22 |
DLEU1 |
deleted in lymphocytic leukemia 1 (non-protein coding) |
5586 |
0.18 |
chr7_75984582_75984890 | 0.22 |
YWHAG |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma |
3612 |
0.2 |
chr10_54357540_54357691 | 0.22 |
RP11-556E13.1 |
|
36750 |
0.23 |
chr11_33746911_33747062 | 0.22 |
CD59 |
CD59 molecule, complement regulatory protein |
2488 |
0.23 |
chr9_5518498_5518649 | 0.22 |
PDCD1LG2 |
programmed cell death 1 ligand 2 |
8003 |
0.25 |
chr3_167780902_167781122 | 0.22 |
GOLIM4 |
golgi integral membrane protein 4 |
32120 |
0.24 |
chr8_41862770_41862921 | 0.22 |
ENSG00000238966 |
. |
38248 |
0.15 |
chr19_7581346_7582140 | 0.22 |
ZNF358 |
zinc finger protein 358 |
739 |
0.45 |
chr7_130602252_130602403 | 0.22 |
ENSG00000226380 |
. |
40029 |
0.17 |
chr12_63702500_63702651 | 0.22 |
AVPR1A |
arginine vasopressin receptor 1A |
157853 |
0.04 |
chr5_82354364_82354515 | 0.22 |
ENSG00000238835 |
. |
5717 |
0.23 |
chr9_21968288_21968979 | 0.22 |
C9orf53 |
chromosome 9 open reading frame 53 |
1496 |
0.32 |
chr3_99591263_99591414 | 0.21 |
FILIP1L |
filamin A interacting protein 1-like |
3610 |
0.31 |
chr3_57094343_57094529 | 0.21 |
SPATA12 |
spermatogenesis associated 12 |
33 |
0.98 |
chr7_143155212_143155383 | 0.21 |
TAS2R60 |
taste receptor, type 2, member 60 |
14751 |
0.13 |
chr9_97811962_97812255 | 0.21 |
ENSG00000207563 |
. |
35382 |
0.12 |
chr8_128003605_128003873 | 0.21 |
ENSG00000212451 |
. |
319972 |
0.01 |
chr9_96932852_96933003 | 0.21 |
ENSG00000199165 |
. |
5307 |
0.17 |
chr10_128993776_128993991 | 0.21 |
FAM196A |
family with sequence similarity 196, member A |
539 |
0.87 |
chr4_86397366_86397517 | 0.21 |
ARHGAP24 |
Rho GTPase activating protein 24 |
1050 |
0.7 |
chr7_13598952_13599103 | 0.21 |
ETV1 |
ets variant 1 |
427039 |
0.01 |
chr12_62998810_62998961 | 0.21 |
ENSG00000199179 |
. |
1419 |
0.27 |
chr4_114214241_114214392 | 0.21 |
ANK2 |
ankyrin 2, neuronal |
178 |
0.97 |
chr1_28385802_28385953 | 0.21 |
EYA3 |
eyes absent homolog 3 (Drosophila) |
1279 |
0.41 |
chr4_134068181_134068851 | 0.21 |
PCDH10 |
protocadherin 10 |
1954 |
0.52 |
chr13_68759883_68760034 | 0.21 |
ENSG00000243671 |
. |
508255 |
0.0 |
chr10_51574745_51574998 | 0.21 |
NCOA4 |
nuclear receptor coactivator 4 |
1414 |
0.4 |
chr1_246149945_246150147 | 0.21 |
RP11-83A16.1 |
|
46807 |
0.18 |
chr2_188416196_188416496 | 0.21 |
AC007319.1 |
|
2530 |
0.3 |
chr8_9415740_9416105 | 0.21 |
RP11-375N15.2 |
|
1892 |
0.35 |
chr4_26909424_26909603 | 0.21 |
STIM2 |
stromal interaction molecule 2 |
46432 |
0.17 |
chr14_55041073_55041224 | 0.21 |
SAMD4A |
sterile alpha motif domain containing 4A |
6511 |
0.25 |
chr6_144355602_144355753 | 0.21 |
PLAGL1 |
pleiomorphic adenoma gene-like 1 |
26136 |
0.22 |
chr3_146755718_146755869 | 0.21 |
ENSG00000207156 |
. |
41293 |
0.2 |
chr12_131401175_131401405 | 0.21 |
ENSG00000206850 |
. |
9907 |
0.18 |
chr9_124031457_124031643 | 0.21 |
GSN |
gelsolin |
1170 |
0.41 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0031223 | auditory behavior(GO:0031223) |
0.1 | 0.2 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.5 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 0.1 | GO:0001743 | optic placode formation(GO:0001743) |
0.0 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.2 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.0 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.0 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.0 | 0.1 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.0 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.1 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.0 | 0.1 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0032430 | obsolete regulation of natriuresis(GO:0003078) positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.2 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.2 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.0 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:2001280 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.0 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.0 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.1 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.0 | GO:0003307 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.0 | GO:0051280 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.4 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.1 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.6 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.0 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0034739 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.2 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID BMP PATHWAY | BMP receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |